News Column

MMR Gets 13 Health Information Technology Patents

June 20, 2014

MMRGlobal, through its wholly owned subsidiary MyMedicalRecords reported that it will receive U.S. Patent No. 8,768,725 (the '725 Patent) from the United States Patent and Trademark Office.

In its release, MMR noted:

The '725 patent includes claims directed to the sharing of records with a second healthcare provider to better manage and facilitate second opinions. MMR will now have a total of 36 patents including 13 domestic health information technology (HIT) patents, seven foreign HIT patents, and 16 biotech patents. Based on licenses pertaining to its U.S. patent portfolio, MMR already has agreements worth more than $40,000,000 as set forth in the agreements. In addition, ongoing royalties from sales and licensing including recurring revenues from retail and laboratory services could easily double that amount. MMR also projects revenue growth from domestic and international retail pharmacies, grocery retail, employee benefit programs, Etailers, affiliate marketers and other eHealth providers including 4medica and a recently signed Patent Agreement with Cerner Corp. For example, MMR expects online Etailer distribution to reach more than 40 million households each month and 12,000 in-store U.S. pharmacies this year. MMR also licensed distribution in European-based pharmacy retailers with more than 1,000 stores.

MyMedicalRecords is a practicing entity and a provider of secure and easy-to-use Personal Health Records (PHRs) through its MyMedicalRecords PHR, and MMRPro and MMRProPlus document management and imaging systems for healthcare professionals. After issuance of Patent No. 8,768,725, MMR's patent portfolio will include 13 U.S. patents, including U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532, 8,645,161; 8,725,537, and including a NOA for Serial No. 13/ 082,896. The patents collectively include over 275 issued claims and there are additional pending applications and continuation applications. The '725 patent is scheduled to issue on July 1. MMR also has similar HIT patents and pending applications in 11 other countries or regional authorities of commercial interest including Australia, Canada, Singapore, New Zealand, Mexico, Hong Kong, China, Japan, South Korea, Israel, and Europe.

The Company has three separate patent portfolios currently comprising the 36 patents and additional pending applications and continuation applications. The first is directed at Electronic Medical Records with a primary focus on Personal Health Records; another portfolio centers around the use of PHRs in connection with Clinical Trials, which MMR plans on licensing through existing relationships with Big Pharma and the biotech community. The third portfolio includes MMRGlobal's legacy biotech patents from the Company's FavId vaccine trials and clinical research related to cancer-fighting anti-CD20 monoclonal antibodies.

Last month the Company also reported a Notice of Allowance for MMR's first Clinical Trials patent which includes 18 claims directed to methods and systems that provide for self-reporting being used to create Electronic Health Records for purposes including clinical trials. At the same time, MMR reported the issuance of U.S. Patent No. 8,725,537, entitled "Method and System for Providing Online Records," which expands MMR's health IT patents with claims directed toward storing, managing and sharing legal records. This patent broadens MMR's intellectual property beyond PHRs and other forms of Electronic Medical Records into the legal field. The '537 patent is particularly relevant to the management of wills and powers of attorney and advanced directives which can be included as part of an individual's Personal Health Record account.

More Information and Complete Details:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Travel & Leisure Close - Up

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters